CYP2C9, CYP4F2, VKORC1 Gene Polymorphism in Buryat Population

被引:1
|
作者
Sambyalova, A. Yu. [1 ]
Bairova, T. A. [1 ]
Belyaeva, E. V. [1 ]
Ershova, O. A. [1 ]
Sargaeva, D. S. [2 ]
Kolesnikov, S. I. [1 ,3 ]
机构
[1] Sci Ctr Family Hlth & Human Reprod Problems, Irkutsk 664003, Russia
[2] Semashko Republican lin Hosp, Ulan Ude 670031, Russia
[3] Moscow MV Lomonosov State Univ, Moscow 119234, Russia
关键词
Buryat population; polymorphism; VKORC1; WARFARIN DOSAGE; VARIANTS; REQUIREMENTS; VARIABILITY; HAPLOTYPES; RS2108622; FREQUENCY; ALLELES; ROMA;
D O I
10.1134/S1022795420120121
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The allele and genotype frequency distribution at polymorphic loci rs1799853 (430C>T) and rs1057910 (A1075C) of the CYP2C9 gene, rs2108622 (1347C>T) of the CYP4F2 gene, and rs9923231 (1639G>A) of the VKORC1 gene in the Buryat population was examined. The study involved 197 volunteers living in the Republic of Buryatia: 124 woman and 73 men, average age of 57.51 +/- 10.88 years. Genetic typing of DNA samples was performed by polymerase chain reaction (RT-PCR). The frequency of the minor alleles *2 and *3 of the CYP2C9 gene was 2.03 and 3.05%, respectively. The frequency of the allele T of the CYP4F2 gene was 31.22%; the frequency of the allele A of the VKORC1 gene was 85.28%. The obtained results could be used in the prognosis of pharmacotherapy of warfarin in the population Buryat population.
引用
收藏
页码:1496 / 1503
页数:8
相关论文
共 50 条
  • [41] A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
    Takeuchi, Fumihiko
    McGinnis, Ralph
    Bourgeois, Stephane
    Barnes, Chris
    Eriksson, Niclas
    Soranzo, Nicole
    Whittaker, Pamela
    Ranganath, Venkatesh
    Kumanduri, Vasudev
    McLaren, William
    Holm, Lennart
    Lindh, Jonatan
    Rane, Anders
    Wadelius, Mia
    Deloukas, Panos
    PLOS GENETICS, 2009, 5 (03):
  • [42] VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY
    Zambon, C. -F.
    Pelloso, M.
    Pengo, V.
    Fogar, P.
    Moz, S.
    Nante, G.
    Russo, R.
    Tiso, E.
    Padrini, R.
    Nisi, A.
    Basso, D.
    Plebani, M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S669 - S669
  • [43] Frequency of polymorphisms in the CYP2C9, VKORC1, and CYP4F2 genes related to the metabolism of Warfarin in healthy donors from Cali, Colombia
    Giraldo-Ocampo, Sebastian
    Diaz-Ordonez, Lorena
    Silva-Cuero, Yisther Katherine
    Gutierrez-Medina, Juan David
    Candelo, Estephania
    Diaz, Javier A.
    Pachajoa, Harry
    MEDICINE, 2023, 102 (30) : E34204
  • [44] Warfarin sensitivity and CYP2C9 and VKORC1 genes
    Bukaveckas, Bonny Lewis
    INFLAMMATION RESEARCH, 2007, 56 : S223 - S224
  • [45] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508
  • [46] Association between CYP2C9, VKORC1 and CYP4F2 genetic variants in anticoagulation related outcomes during initiation period in acenocoumarol therapy
    Cerezo-Manchado, J. J.
    Gonzalez-Conejero, R.
    Ana Isabel, A.
    Constatino, M.
    Perez-Andreu, V
    Nuria, G. B.
    Jose, P.
    Vicente, V.
    Vanessa, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 561 - 561
  • [47] Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population
    Dhakchinamoorthi Krishna Kumar
    Deepak Gopal Shewade
    Marie-Anne Loriot
    Philippe Beaune
    Jayaraman Balachander
    B. V. Sai Chandran
    Chandrasekaran Adithan
    European Journal of Clinical Pharmacology, 2014, 70 : 47 - 56
  • [48] Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population
    Kumar, Dhakchinamoorthi Krishna
    Shewade, Deepak Gopal
    Loriot, Marie-Anne
    Beaune, Philippe
    Balachander, Jayaraman
    Chandran, B. V. Sai
    Adithan, Chandrasekaran
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (01) : 47 - 56
  • [49] Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients
    Elkhazraji, Abdelhak
    Bouaiti, El Arbi
    Boulahyaoui, Hassan
    Nahmtchougli, Christiana Philippa
    Zahid, Hafid
    Bensaid, Mounia
    Ibrahimi, Azeddine
    Messaoudi, Nezha
    DRUG DISCOVERIES AND THERAPEUTICS, 2018, 12 (02): : 68 - 76
  • [50] Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients (vol 20, pg 393, 2016)
    Wakamiya, Takuya
    Hokosaki, Tatsunori
    Tsujimoto, Shin-ichi
    Kadota, Keisuke
    Nakano, Yusuke
    Watanabe, Shigeo
    Iwamoto, Mari
    Yanagimachi, Masakatsu
    Ito, Shuichi
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (05) : 501 - 501